A guanine-derived ANTINEOPLASTIC AGENT that functions as a NUCLEIC ACID SYNTHESIS INHIBITOR through its binding to, and inhibition of, THYMIDYLATE SYNTHASE.
Pemetrexed has been studied across 12 research domains including 🔬 Oncology, ⏳ Longevity & Aging, 🫘 Kidney, ⚡ Energy & Fatigue, 😴 Sleep. The primary research focus is 🔬 Oncology with 84% of studies addressing this area.
The following compounds share molecular targets with Pemetrexed, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Pemetrexed is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.